HEALTHSTAT NEWS
STAT+: Competition for obesity drugs, clinical blind spots, and more news from ADA
The article discusses updates on competition in obesity drugs, insights on eating disorders, new information on a BCG vaccine, and a clarification from the American Diabetes Association regarding a police incident. It is part of STAT’s coverage from the ADA annual conference.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Pharmalittle: We’re reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more
- STAT+: Triple hormone receptors, a monthly obesity drug, and a bittersweet ending
- France to partially reimburse weight-loss drugs for obesity patients
- Daily briefing: What it will take to stop the spiralling Ebola outbreak
- STAT+: Pharmalittle: We’re reading about a Lilly obesity drug trial, statistics for an Alzheimer’s drug, and more
- Scientists uncover a new hiding spot for HIV